📣 First trial of vaccine to prevent Lynch syndrome-associated cancers approved to start in Oxford.
Fantastic news from @ox.ac.uk & Moderna that Phase 1 of the INTERCEPT-Lynch trial has received MHRA authorisation & is expected to begin recruitment this summer.
tinyurl.com/intercept-ly...